Literature DB >> 30498725

Adjuvant antiviral therapy for the prevention of hepatocellular carcinoma recurrence after liver resection: indicated for all patients with chronic hepatitis B?

Clifford Akateh1, Timothy M Pawlik1, Jordan M Cloyd1.   

Abstract

Entities:  

Year:  2018        PMID： 30498725      PMCID： PMC6230855          DOI： 10.21037/atm.2018.08.20

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

1.  HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.

Authors:  Won Sohn; Yong-Han Paik; Jong Man Kim; Choon Hyuk Kwon; Jae Won Joh; Ju Yeon Cho; Geum-Youn Gwak; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Ann Surg Oncol       Date:  2014-03-12       Impact factor: 5.344

Review 2.  Hepatitis B virus X gene and hepatocarcinogenesis.

Authors:  Sue-Ann Ng; Caroline Lee
Journal:  J Gastroenterol       Date:  2011-06-08       Impact factor: 7.527

3.  Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study.

Authors:  Jianhua Yin; Nan Li; Yifang Han; Jie Xue; Yang Deng; Jie Shi; Weixing Guo; Hongwei Zhang; Hongyang Wang; Shuqun Cheng; Guangwen Cao
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

Review 4.  Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy.

Authors:  George V Papatheodoridis; Henry Lik-Yuen Chan; Bettina E Hansen; Harry L A Janssen; Pietro Lampertico
Journal:  J Hepatol       Date:  2015-01-13       Impact factor: 25.083

5.  Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients.

Authors:  Akihiro Matsumoto; Eiji Tanaka; Akinori Rokuhara; Kendo Kiyosawa; Hiromitsu Kumada; Masao Omata; Kiwamu Okita; Norio Hayashi; Takeshi Okanoue; Shiro Iino; Kyuichi Tanikawa
Journal:  Hepatol Res       Date:  2005-07-18       Impact factor: 4.288

6.  Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus.

Authors:  Jung Il Lee; Ja Kyung Kim; Hye Young Chang; Jin-Woo Lee; Joon Mee Kim; Hyun Jung Chung; Young Soo Kim; Kwan Sik Lee
Journal:  J Gastroenterol Hepatol       Date:  2014-05       Impact factor: 4.029

7.  Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial.

Authors:  Gang Huang; Wan Yee Lau; Zhen-Guang Wang; Ze-Ya Pan; Sheng-Xian Yuan; Feng Shen; Wei-Ping Zhou; Meng-Chao Wu
Journal:  Ann Surg       Date:  2015-01       Impact factor: 12.969

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma.

Authors:  Makoto Chuma; Shuhei Hige; Toshiya Kamiyama; Takashi Meguro; Atsushi Nagasaka; Kazuaki Nakanishi; Yoshiya Yamamoto; Mitsuru Nakanishi; Toshihisa Kohara; Takuya Sho; Keiko Yamamoto; Hiromasa Horimoto; Tomoe Kobayashi; Hideki Yokoo; Michiaki Matsushita; Satoru Todo; Masahiro Asaka
Journal:  J Gastroenterol       Date:  2009-06-25       Impact factor: 7.527

10.  The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.

Authors:  Tomi Akinyemiju; Semaw Abera; Muktar Ahmed; Noore Alam; Mulubirhan Assefa Alemayohu; Christine Allen; Rajaa Al-Raddadi; Nelson Alvis-Guzman; Yaw Amoako; Al Artaman; Tadesse Awoke Ayele; Aleksandra Barac; Isabela Bensenor; Adugnaw Berhane; Zulfiqar Bhutta; Jacqueline Castillo-Rivas; Abdulaal Chitheer; Jee-Young Choi; Benjamin Cowie; Lalit Dandona; Rakhi Dandona; Subhojit Dey; Daniel Dicker; Huyen Phuc; Donatus U. Ekwueme; Maysaa El Sayed Zaki; Florian Fischer; Thomas Fürst; Jamie Hancock; Simon I. Hay; Peter Hotez; Sun Ha Jee; Amir Kasaeian; Yousef Khader; Young-Ho Khang; Anil Kumar; Michael Kutz; Heidi Larson; Alan Lopez; Raimundas Lunevicius; Reza Malekzadeh; Colm McAlinden; Toni Meier; Walter Mendoza; Ali Mokdad; Maziar Moradi-Lakeh; Gabriele Nagel; Quyen Nguyen; Grant Nguyen; Felix Ogbo; George Patton; David M. Pereira; Farshad Pourmalek; Mostafa Qorbani; Amir Radfar; Gholamreza Roshandel; Joshua A Salomon; Juan Sanabria; Benn Sartorius; Maheswar Satpathy; Monika Sawhney; Sadaf Sepanlou; Katya Shackelford; Hirbo Shore; Jiandong Sun; Desalegn Tadese Mengistu; Roman Topór-Mądry; Bach Tran; Vasiliy Vlassov; Stein Emil Vollset; Theo Vos; Tolassa Wakayo; Elisabete Weiderpass; Andrea Werdecker; Naohiro Yonemoto; Mustafa Younis; Chuanhua Yu; Zoubida Zaidi; Liguo Zhu; Christopher J. L. Murray; Mohsen Naghavi; Christina Fitzmaurice
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777
View more
  2 in total

1.  An alternative splicing signature model for predicting hepatocellular carcinoma-specific survival.

Authors:  Sheng Dong; Li-Jun Lu
Journal:  J Gastrointest Oncol       Date:  2020-10

Review 2.  Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.

Authors:  Clifford Akateh; Sylvester M Black; Lanla Conteh; Eric D Miller; Anne Noonan; Eric Elliott; Timothy M Pawlik; Allan Tsung; Jordan M Cloyd
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.